SCHEMBL16320175

SCHEMBL16320175

Cc1cc(Nc2cc(C(C)(C)C)n[nH]2)nc(Nc2ccc(NC(=S)Nc3ccc(Cl)c(C(F)(F)F)c3)nc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.39
BRAF P15056 5/20 0.39
RAF1 P04049 3/20 0.38
MAPK3 P27361 2/20 0.38
KDR P35968 4/20 0.37
FLT3 P36888 2/20 0.37
KIT P10721 1/20 0.37
MAPK14 Q16539 1/20 0.37
BTK Q06187 1/20 0.36
TEK Q02763 1/20 0.36
EGFR P00533 3/20 0.36
MAPT P10636 1/20 0.36
ABL1 P00519 2/20 0.36
BCR P11274 2/20 0.36
ALDH1A1 P00352 2/20 0.35
GAA P10253 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
HSP90AA1 P07900 1/20 0.35
IGF1R P08069 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16319556 0.92 LMNA (0.42) LMNABRAFRAF1MAPK3KDR
SCHEMBL16319853 0.91 TEK (0.45) BRAFRAF1KDRFLT3MAPK14
SCHEMBL16320148 0.91 BRAF (0.41) LMNABRAFRAF1MAPK3KDR
SCHEMBL16320251 0.91 LMNA (0.41) LMNABRAFRAF1MAPK3KDR
SCHEMBL16320294 0.91 LMNA (0.41) LMNABRAFRAF1MAPK3KDR
SCHEMBL16319952 0.90 LMNA (0.40) LMNABRAFRAF1MAPK3KDR
SCHEMBL16319466 0.89 LMNA (0.39) LMNABRAFRAF1MAPK3KDR
SCHEMBL16319706 0.88 KDR (0.40) LMNABRAFRAF1MAPK3KDR
SCHEMBL16320437 0.88 LMNA (0.43) LMNABRAFRAF1MAPK3KDR
SCHEMBL16319837 0.88 KDR (0.42) LMNABRAFRAF1MAPK3KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9221798-B2 4-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof Zhejian Hisun Pharmaceutical Co., Ltd. (CN) 2015-12-29 US disclosed
US-20140378488-A1 4-SUBSTITUTED-(3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO)-PYRIMIDINE DERIVATIVES HAVING ACTIVITY OF INHIBITING PROTEIN KINASE AND USE THEREOF ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (CN) 2014-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378488-A1 4-SUBSTITUTED-(3-SUBSTITUTED-1H-PYRAZOLE-5-AMINO)-PYRIMIDINE DERIVATIVES HAVING ACTIVITY OF INHIBITING PROTEIN KINASE AND USE THEREOF MAP4K2, MAP4K1, MAP4K3 LMNA 3831/4885BRAF 84/4885RAF1 53/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.